Skip to content
hcg-service-hero-1

Insights From Halloran

Laura GilliamFeb 27, 2024 8:56:00 AM5 min read

Pulling the Thread on FDA’s Master Protocol Draft Guidance 

The U.S. Food and Drug Administration’s (FDA) draft guidance, Master Protocols for Drug ...
Start Reading
Halloran Consulting GroupFeb 26, 2024 4:39:00 PM3 min read

Clinical Trial Leadership: Enhancing Efficiencies and Reducing Risk

Situation
Start Reading
Emily MarschokFeb 23, 2024 12:20:00 PM1 min read

Moving from Research to Development

The journey from research to development is a critical milestone for any biotech startup. ...
Start Reading
Rashida ChallengerFeb 23, 2024 12:17:00 PM2 min read

Diversity in Clinical Trials: Shifting from Challenge to Innovation Opportunity  

In the dynamic landscape of clinical research, ensuring diversity in clinical trials has ...
Start Reading
Halloran Consulting GroupFeb 22, 2024 12:21:00 PM9 min read

5 Broad Implications for Project Optimus: Future of Oncology Trials

Oncology drug development is different from most drug development programs in other ...
Start Reading
Halloran Consulting GroupFeb 15, 2024 12:16:00 PM8 min read

Reconsidering the 3+3 Dose Escalation in Oncology Studies

Many product developers are propelled by the goal of delivering life-saving treatments as ...
Start Reading
Rashida ChallengerFeb 15, 2024 11:45:00 AM3 min read

Trial Rescue: Leadership Approach Propels Clinical Development

Situation
Start Reading
Halloran Consulting GroupJan 24, 2024 12:05:00 PM2 min read

Why The FDA Modernization Act 2.0 is The Challenge Our Industry Needs 

Shawn Roach, one of Halloran’s Regulatory Chemistry, Manufacturing, and Controls (CMC) ...
Start Reading
Rashida ChallengerJan 23, 2024 12:16:00 PM2 min read

Clinical Trial Manager to The Rescue: The Halloran Approach 

Clinical trials are essential for bringing new treatments to patients. However, not all ...
Start Reading
Jillian FarrelJan 16, 2024 11:31:00 AM6 min read

Navigating the Patient Clinical Trial Training Matrix

Content in collaboration with ScienceMedia Authors: Malachi Bierstein, Chief Commercial ...
Start Reading